Home > Insider Trading > Filing (0001209191-20-039019)

Filing Details

Accession Number:: 0001209191-20-039019
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-25 19:40:23
Reporting Period:: 2020-06-23

Accepted Time:: 2020-06-25 19:40:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1808158	Repare Therapeutics Inc.	RPTX	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1765253	Versant Vantage I, L.p.	One Sansome, Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777651	Versant Vantage I Gp, L.p.	One Sansome, Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777653	Versant Vantage I Gp-Gp, Llc	One Sansome, Suite 3630 San Francisco CA 94104	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-06-23	2,054,198	$0.00	2,705,660	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	156,335	$0.00	205,915	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	68,398	$0.00	90,090	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	61,791	$0.00	81,387	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	2,443,883	$0.00	2,443,883	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	111,361	$0.00	2,817,021	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	8,475	$0.00	214,390	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	3,708	$0.00	93,798	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	3,350	$0.00	84,737	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	875,568	$0.00	3,319,451	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	458,282	$0.00	458,282	No	4	C	Indirect	See Footnote
Common Shares	Acquisiton	2020-06-23	150,000	$20.00	608,282	No	4	P	Indirect	See Footnotes
Common Shares	Acquisiton	2020-06-23	100,000	$20.00	3,419,451	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Class A Preferred Shares	Disposition	2020-06-23	2,054,198	$0.00	2,054,198	$0.00
Common Shares	Class A Preferred Shares	Disposition	2020-06-23	156,335	$0.00	156,335	$0.00
Common Shares	Class A Preferred Shares	Disposition	2020-06-23	68,398	$0.00	68,398	$0.00
Common Shares	Class A Preferred Shares	Disposition	2020-06-23	61,791	$0.00	61,791	$0.00
Common Shares	Class A Preferred Shares	Disposition	2020-06-23	2,443,883	$0.00	2,443,883	$0.00
Common Shares	Class B Preferred Shares	Disposition	2020-06-23	111,361	$0.00	111,361	$0.00
Common Shares	Class B Preferred Shares	Disposition	2020-06-23	8,475	$0.00	8,475	$0.00
Common Shares	Class B Preferred Shares	Disposition	2020-06-23	3,708	$0.00	3,708	$0.00
Common Shares	Class B Preferred Shares	Disposition	2020-06-23	3,350	$0.00	3,350	$0.00
Common Shares	Class B Preferred Shares	Disposition	2020-06-23	875,568	$0.00	875,568	$0.00
Common Shares	Class B Preferred Shares	Disposition	2020-06-23	458,282	$0.00	458,282	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each Series A Preferred Share and each Series B Preferred Share converted into the same number of Common Shares upon the closing of the Issuer's initial public offering and had no expiration date.
The securities are held by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VVC V, except to the extent of its pecuniary interest therein.
The securities are held by Versant Venture Capital V (Canada) LP ("VVC(Canada)"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). By virtue of such relationships, VV V (Canada) GP and VV V (Canada) may be deemed to have voting and investment power over the securities held by VVC V (Canada) and as a result may be deemed to have beneficial ownership over such securities. Each of VV V (Canada) and VV V (Canada) GP disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of its pecuniary interest therein.
The securities are held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"). VV V is the sole general partner of VOAF I and may be deemed to have voting and investment power over the securities held by VOAF I and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VOAF I, except to the extent of its pecuniary interest therein.
The securities are held by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VAF V, except to the extent of its pecuniary interest therein.
The securities are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. By virtue of such relationships, VV VI GP and VV VI may be deemed to have voting and investment power over the securities held by VVC VI and as a result may be deemed to have beneficial ownership over such securities. Each of VV VI GP and VV VI disclaims beneficial ownership of the shares held by VVC VI, except to the extent of its pecuniary interest therein.
The securities are held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. By virtue of such relationships, VV I GP and VV I GP-GP may be deemed to have voting and investment power over the securities held by VV I and as a result may be deemed to have beneficial ownership over such securities. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of its pecuniary interest therein.
These securities were purchased by VV I.
These securities were purchased by VVC VI.